Insider Transactions in Q3 2021 at Bluebird Bio, Inc. (BLUE)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2021
|
Najoh Tita Reid |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+50.0%
|
-
|
|
Sep 29
2021
|
Sarah Js Glickman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+50.0%
|
-
|
|
Sep 07
2021
|
Marcela V. Maus Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,663
+50.0%
|
-
|
|
Aug 02
2021
|
Andrew Obenshain President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+41.74%
|
-
|
|
Aug 02
2021
|
Jason Cole Chief Strategy & Financial Off |
BUY
Grant, award, or other acquisition
|
Direct |
64,531
+25.49%
|
-
|
|
Aug 02
2021
|
Nick Leschly |
BUY
Grant, award, or other acquisition
|
Direct |
102,607
+11.84%
|
-
|
|
Aug 02
2021
|
William D Baird Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
67,169
+28.67%
|
-
|
|
Aug 02
2021
|
Philip D Gregory Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
67,853
+26.21%
|
-
|